In MS, a reduction of pro-inflammatory Th1 cytokines interferon-γ and IL-12, increased secretion of the anti-inflammatory Th2 cytokines IL-4 and IL-10 in CSF and peripheral blood, and a re-shaping of T cell subsets towards a less inflammatory phenotype were reported [244]. This evidence concerns the gene IL4 and myeloid sarcoma.